Skip to main content
Premium Trial:

Request an Annual Quote

ABI Shares Up 13 Percent as Fiscal Q1 Revenue Surges

NEW YORK (GenomeWeb News) — Shares in Applied Biosystems were up 13.04 percent, or $4.40, at $37.91 in mid-afternoon trading today after the company said fiscal first quarter revenues increased 15 percent.
 
Separately today, investment bank UBS upgraded ABI’s stock to ‘Neutral’ from ‘Reduce.’
 
As GenomeWeb News reported today, ABI reported that for the three months ended Sept. 30 total sales increased to $476.3 million from $415.5 million last year
 
ABI said that sequencing revenue increased 5.2 percent to $131.5 million from $124.9 million in the year ago period; RT-PCR sales increased 30 percent to $158.1 million; mass spec sales increase 19 percent in the period to $116 million; core PCR and DNA synthesis declined 3 percent to $46.2 million; and “other” products increased 1 percent to $24.5 million.

The Scan

Researchers Develop Polygenic Risk Scores for Dozens of Disease-Related Exposures

With genetic data from two large population cohorts and summary statistics from prior genome-wide association studies, researchers came up with 27 exposure polygenic risk scores in the American Journal of Human Genetics.

US Survey Data Suggests Ancestry Testing Leads Way in Awareness, Use of Genetic Testing Awareness

Although roughly three-quarters of surveyed individuals in a Genetics in Medicine study reported awareness of genetic testing, use of such tests was lower and varied with income, ancestry, and disease history.

Coral Genome Leads to Alternative Amino Acid Pathway Found in Other Non-Model Animals

An alternative cysteine biosynthesis pathway unearthed in the Acropora loripes genome subsequently turned up in sequences from non-mammalian, -nematode, or -arthropod animals, researchers report in Science Advances.

Mosquitos Genetically Modified to Prevent Malaria Spread

A gene drive approach could be used to render mosquitos unable to spread malaria, researchers report in Science Advances.